Pragmatic AI-Assisted Lung Cancer Translational Study
Key facts
- Who runs it
- Sir Run Run Shaw Hospital
- Where
- China3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 30 Nov 2026
- Type of study
- Interventional
- Treatments tested
- Revision of Medical Records
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Providers:
- Junior physicians (less than 2 years of clinical experience) working in the departments of respiratory medicine, thoracic surgery, or oncology at the participating center
- Currently undergoing standardized residency training
- Primarily responsible for writing clinical notes and placing/verifying non-critical medical or surgical orders in routine practice; Patients:
- Adults aged 18 years or older with a confirmed diagnosis of lung cancer
- Managed by participating physicians during the study period
- Received complete diagnostic evaluation and treatment at the participating center
Who cannot take part
- Providers:
- Interns, students, or auxiliary staff who are not directly responsible for writing clinical notes
- Physicians who refuse to use the AI tool or are unable to complete the study workflow
- Patients whose records are managed by non-participating physicians; Patients:
- Non-standard admissions that do not follow standard inpatient documentation workflows, or cases where note quality or order accuracy cannot be evaluated
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study is to learn whether an artificial intelligence (AI) tool helps healthcare providers write and revise medical notes and check medical orders. This prospective study compares routine documentation without AI to documentation with AI assistance. The AI tool helps draft notes and review orders, but it does not make treatment decisions. Researchers will compare the quality of the notes, the time spent writing them, and the number of order errors between the two methods. The results will help hospitals decide if AI can improve daily clinical workflows.
The group in the trial
- Self-Controlled Group:Sequential manual and AI-AssistedTreatment being tested
This study uses a before-and-after self-controlled design; therefore, it is a single-arm study.
Treatment: Revision of Medical Records
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pragmatic Translational Study of AI-Assisted Lung Cancer Diagnosis and Treatment
- Record updated
- 17 November 2026